Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Cash Flows From Operating Activities:
Net income (loss)	$ (60,469)	$ (3,286,804)
Adjustments to reconcile net income (loss) to net cash provided (used) by operating activities:
Depreciation and amortization	880,880	885,843
Loss on mineral properties	0	318,502
Accretion of asset retirement obligation	6,930	7,851
Common stock payable for directors fees	112,500	106,108
Gain on settlement of Hillgrove advance	(113,422)	0
Gain of forgiveness of Cares Act debt	(443,400)	0
Loss on disposal of assets	74,259	0
Other non cash item	0	(660)
Change in:
Accounts receivable	(652,680)	45,819
Inventories	(405,207)	(23,969)
IVA receivable and other assets	(34,249)	(38,361)
Accounts payable	(491,120)	(452,103)
Accrued liabilities	(13,753)	(2,662)
Export tax assessment payable	(1,120,730)	1,120,730
Payables to related parties	171,016	14,042
Net cash provided (used) by operating activities	(2,431,477)	(1,305,664)
Cash Flows From Investing Activities:
Proceeds from redemption of certificates of deposit	210,002	0
Purchase of certificate of deposit	(215,000)	0
Purchase of properties, plants and equipment	(648,128)	(243,091)
Net cash provided (used) by investing activities	(653,126)	(243,091)
Cash Flows From Financing Activities:
Change in checks issued and payable	(86,685)	69,052
Proceeds from issuance of common stock and warrants, net of issuance costs	23,342,178	1,813,068
Proceeds from exercise of warrants	1,790,705	0
Payments on Hillgrove advances payable	(1,020,799)	0
Payments on advances from related party	(56,418)	(83,419)
Proceeds from CARES Act Note Payable	0	443,400
Proceeds (payments) on notes payable to bank, net	(100,000)	(97,066)
Principal payments of long-term debt	(86,426)	(46,670)
Net cash provided (used) by financing activities	23,782,555	2,098,365
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH	20,697,952	549,610
Cash and cash equivalents at beginning of year	722,377	172,767
Cash and cash equivalents at beginning of year	21,420,329	722,377
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION
Interest paid in cash	5,539	17,991
Noncash investing and financing activities:
Common stock payable issued to directors	110,000	130,483
Payable to related party satisfied with exercise of stock purchase warrant	0	62,500
Building purchased with note payable	$ 215,150	$ 0